Rey Suarez was the keynote speaker at the Preparatory Commission of the Comprehensive Nuclear-Test-Ban Treaty Organization’s Specialized Technical Meeting on Preventive and Predicative Maintenance of the International Monitoring System.
Brian Milbrath, a physicist in PNNL’s National Security Directorate, was named a senior member of the Institute of Electrical and Electronics Engineers (IEEE).
In recognition of Nuclear Science Week on Oct. 19-23, Pacific Northwest National Laboratory reflects on more than half a century of advancing nuclear science for the nation’s energy, environment, and security frontiers.
Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.
Pacific Northwest National Laboratory (PNNL) is part of a continuing National Science Foundation (NSF) team investigating the environmental impact of nanoparticles at the molecular level.
Radiation from natural sources in the environment can limit the performance of superconducting quantum bits, known as qubits. The discovery has implications for quantum computing and for the search for dark matter.
A cadre of physical scientists, engineers and computing experts at Pacific Northwest National Laboratory is poised to participate in the launch of three new DOE Office of Science-sponsored quantum information science research centers.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.
After years of planning, building, and calibration, researchers at the Belle II accelerator experiment in Japan have published their first physics paper.
After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.